357 Results (Page 1 of 15)
Vietnam Markets Research Reports
Vietnam Contact Lenses Market Analysis
Vietnam Contact Lenses Market was valued at $85.70 Mn in 2023 and is predicted to grow at a CAGR of 9.13% from 2023 to 2030, $157.98 Mn by 2030. The key drivers of this industry include the rising vision problems, growing disposable income, increased awareness and convenience, and shifting preference towards daily disposables. The industry is primarily dominated by Bausch and Lomb, CooperVision, Alcon Vision, and Essilor among others.
Vietnam Genomics Market Analysis
The Vietnam Genomics market was valued at $163.2 Mn in 2023 and is predicted to grow at a CAGR of 16.73% from 2023 to 2030, to $482.1 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Vietnam genomics market are Gene Solutions, Medics Genetics, Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), and Medical Genetics Institute (MGI), among others.
Vietnam Graft-versus-Host Disease (GvHD) Therapeutics Market Analysis
The Vietnam GvHD Therapeutics Market was valued at $12.5 Mn in 2023 and is predicted to grow at a CAGR of 8.33% from 2023 to 2030, to $21.89 Mn by 2030. Such growth has been driven by factors like improvement in health infrastructure, better research, growing awareness, and medical tourism. The key players in this competitive market are Incyte, MaaT, Mesoblast, Kadmon, Jazz, Neovii, and Novartis among others.
Vietnam Kidney Cancer Therapeutics Market Analysis
Vietnam Kidney Cancer Therapeutics Market was valued at $31.45 Mn in 2023 and is predicted to grow at a CAGR of 5.09% from 2023 to 2030, to $44.52 Mn by 2030. The key drivers of this industry include the Increasing incidence of kidney cancer, Advances in targeted therapies, Growing geriatric population. The industry is primarily dominated by Pfizer Inc, AstraZeneca, Bristol-Myers Squibb Company, Dr. Reddy’s Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, and Sun Pharmaceutical Industries Ltd among others.
Vietnam Medical Digital Imaging System Market Analysis
The Vietnam Medical Digital Imaging System Market was valued at $152.5 Mn in 2023 and is predicted to grow at a CAGR of 8.43% from 2023 to 2030, to $268.73 Mn by 2030. The key drivers of this industry include an aging population, rising disease burden, and government support. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Vietnam Exosome Research Market Analysis
The Vietnam Exosome Research Market was valued at $0.8 Mn in 2023 and is projected to grow at a CAGR of 16.23% from 2023 to 2023, to $2.4 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, QIAGEN, Lonza among others.
Vietnam Dental Caries Detectors Market Analysis
The Vietnam Dental Caries Detectors Market was valued at $1.1 Mn in 2023 and is predicted to grow at a CAGR of 9.13% from 2023 to 2030, to $2.1 Mn by 2030. Vietnam Dental Caries Detectors Market is growing due to High Prevalence of Dental Caries, Increasing Dental Awareness and Education, Government Support, and Healthcare Investments. The market is primarily dominated by players such as Church and Dwight Co. Inc., Lion Corporation, Dentaid, Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, and Planmeca.
Vietnam Clinical Nutrition for Diabetes Care Market Analysis
The Vietnam Clinical Nutrition for Diabetes Care Market was valued at $10.75 Mn in 2023 and is predicted to grow at a CAGR of 5.01% from 2023 to 2030, to $15.14 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Roche Diabetes Care, Sanofi and Novo Nordisk among others.
Vietnam Pharmacy Automation Device Market Analysis
The Vietnam Pharmacy Automation Device Market was valued at $27.5 Mn in 2023 and is predicted to grow at a CAGR of 10.13% from 2023 to 2030, to $54 Mn by 2030. Vietnam Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Kawasaki Heavy Industries Ltd., Fanuc Corporation, Kuka Ag, Mitsubishi Electric Corporation, Becton Dickinson and Co, Capsa Solutions LLC, McKaesson Corporation; Pearson Medical Technologies.
Vietnam Cardiac Pacemakers Market Analysis
The Vietnam Cardiac Pacemakers Market was valued at $20.23 Mn in 2023 and is predicted to grow at a CAGR of 3.43% from 2023 to 2030, to $25.62 Mn by 2030. The key drivers of this industry include increasing disease burden, aging population, and healthcare infrastructure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Vietnam Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Vietnam Clinical Nutrition for Chronic Kidney Diseases Market was valued at $7.80 Mn in 2023 and is predicted to grow at a CAGR of 6.26% from 2023 to 2030, to $12 Mn by 2030. The key drivers of this industry include the rising chronic disease burden, the aging population, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Vietnam Clinical Nutrition for Cancer Care Market Analysis
The Vietnam Clinical Nutrition for Cancer Care Market was valued at $28.1 Mn in 2023 and is predicted to grow at a CAGR of 5.27% from 2023 to 2030, to $40.3 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. The prominent players of the Vietnam Clinical Nutrition for Cancer Care Market are Fonterra, FriesLand Campina, Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.
Vietnam Gram-Negative Infection Therapeutics Market Analysis
The Vietnam Gram-Negative Infection Therapeutics Market was valued at $74.4 Mn in 2023 and is predicted to grow at a CAGR of 6.13% from 2023 to 2030 to $112.8 Mn by 2030. This growth is fuelled by factors such as the increasing prevalence of antibiotic resistance, elevated rates of colonization with resistant strains, and rising mortality rates. Key players in this market include Merck, Takeda, Novartis, and other notable companies.
Vietnam Home Infusion Therapy Market
The Vietnam Home Infusion Therapy Market was valued at $179.8 Mn in 2023 and is predicted to grow at a CAGR of 8.33% from 2023 to 2030, to $314.8 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Vietnam Home Infusion Therapy Market are QMed Asia, Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Vietnam Hepatitis A Therapeutics Market Analysis
The Vietnam Hepatitis A Therapeutics Market was valued at $3.69 Mn in 2023 and is predicted to grow at a CAGR of 2.43% from 2023 to 2030 to $4.36 Mn by 2030. This expansion is mainly fuelled by supportive government initiatives and healthcare expenditure, economic growth, and rising travel and tourism. Leading companies in this market include GSK and F. Hoffmann-La Roche Ltd., among others.
Vietnam Congestive Heart Failure Therapeutics Market Analysis
The Vietnam Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $51.5 Mn in 2022 to $82.3 Mn by 2030, with a CAGR of 6.03% during the forecast period of 2022-2030. The drivers include the increase in CHF prevalence due to aging populations, unhealthy lifestyles, and improved diagnostics, coupled with heightened awareness, early detection efforts, and persistent unmet medical needs among CHF patients, creating opportunities for innovative therapeutics. The Vietnam Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Novartis, Sanofi, Abbott Laboratories, Pfizer, Traphaco, Mekophar, Domesco, Hau Giang Pharmaceutical, Pharmedic, etc., among various others.
Vietnam Antiviral Drugs Market Analysis
This report presents a strategic analysis of the Vietnam Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Antiviral Drugs Market, offering unmatched value, accuracy and expert insights.
Vietnam Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Vietnam nutrition and supplements market will reach a value of $3.2 Bn from $1.91 Bn in 2022, growing at a CAGR of 6.53% during 2022-30. The market is primarily dominated by local players such as DHA Group, Vina Pharma, and Greenlife Nutrition. The market for nutrition and supplements in Vietnam is primarily driven by an inclination towards imported products and increasing consumer awareness of health and lifestyle. This market is segmented by type, product, application, and distribution channel.
Vietnam Cholesterol Therapeutics Market Analysis
The Vietnam Cholesterol Therapeutics Market is anticipated to experience a growth from $121.5 Mn in 2022 to $151.9 Mn by 2030, with a CAGR of 2.83% during the forecast period of 2022-2030. Drivers that collectively contribute to the accelerated growth of the market include the increased chronic disease burden in Vietnam especially CVDs, the changing demographic lifestyles, and the advancements in medical technology providing better treatment options. The Vietnam Cholesterol Therapeutics Market encompasses various players across different segments such as Pfizer, Sanofi, Bayer, AstraZeneca, Novartis, Merck, GSK, Daiichi Sankyo, Traphaco, DHG Pharma, etc, among various others.
Vietnam Clinical Trials Support Service Market Analysis
This report presents a strategic analysis of the Vietnam Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.
Vietnam Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Vietnam Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Vietnam Obesity Drugs Market Analysis
This report presents a strategic analysis of the Vietnam Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Obesity Drugs Market, offering unmatched value, accuracy and expert insights.
Vietnam Clinical Diagnostics Market Analysis
This report presents a strategic analysis of the Vietnam Clinical Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Clinical Diagnostics Market, offering unmatched value, accuracy and expert insights.
Vietnam Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the Vietnam Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
Vietnam Conjunctivitis Therapeutics Market Analysis
The Vietnam Conjunctivitis Therapeutics Market was valued at $21 Mn in 2022 and is predicted to grow at a CAGR of 5.63% from 2023 to 2030, to $32 Mn by 2030. The key drivers of this industry include the increasing prevalence of conjunctivitis, expanding healthcare infrastructure, and increasing treatment options. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Novartis, Rohto, Santen, Pfizer, and Mentholatum among others.